HIKAL
Quarterly Results Analysis [Dec2024]
HIKAL Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹448 Cr | ₹453 Cr | ₹407 Cr | ₹514 Cr | ₹448 Cr | ₹435 Cr | ₹388 Cr | ₹545 Cr |
Expenses | ₹376 Cr | ₹378 Cr | ₹349 Cr | ₹420 Cr | ₹383 Cr | ₹377 Cr | ₹338 Cr | ₹457 Cr |
Operating Income | ₹72 Cr | ₹75 Cr | ₹58 Cr | ₹94 Cr | ₹65 Cr | ₹58 Cr | ₹50 Cr | ₹88 Cr |
Other Income | ₹4 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
Interest | ₹19 Cr | ₹19 Cr | ₹20 Cr | ₹15 Cr | ₹14 Cr | ₹13 Cr | ₹14 Cr | ₹13 Cr |
Depreciation | ₹33 Cr | ₹32 Cr | ₹32 Cr | ₹32 Cr | ₹29 Cr | ₹29 Cr | ₹28 Cr | ₹27 Cr |
Profit Before Tax | ₹24 Cr | ₹25 Cr | ₹7 Cr | ₹47 Cr | ₹22 Cr | ₹17 Cr | ₹10 Cr | ₹49 Cr |
Profit After Tax | ₹17 Cr | ₹18 Cr | ₹5 Cr | ₹34 Cr | ₹16 Cr | ₹13 Cr | ₹7 Cr | ₹36 Cr |
EPS | ₹1.39 | ₹1.48 | ₹0.41 | ₹2.76 | ₹1.30 | ₹1.02 | ₹0.56 | ₹2.92 |
Industry Peers & Returns | 1W | 1M | 1Y |
HIKAL | -4.5% | -10.7% | 30.6% |
SUN PHARMACEUTICAL INDUSTRIES | -3.4% | -0.2% | 18.1% |
DIVIS LABORATORIES | -2.3% | 3.4% | 55.5% |
CIPLA | -2.6% | -0.6% | 5.9% |
TORRENT PHARMACEUTICALS | -2.3% | -2.1% | 20.4% |
DR REDDYS LABORATORIES | -2.9% | -0.2% | -8.7% |
MANKIND PHARMA | 2.2% | 0.3% | 5% |
ZYDUS LIFESCIENCES | -1.5% | -3.2% | -11.1% |
LUPIN | -2.1% | -3.9% | 25.1% |
HIKAL Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.15 % |
Y-o-Y | 0.04 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹448 Cr | -1.15 | |
Sep2024 | ₹453 Cr | 11.33 | |
Jun2024 | ₹407 Cr | -20.87 | |
Mar2024 | ₹514 Cr | 14.88 | |
Dec2023 | ₹448 Cr | 2.90 | |
Sep2023 | ₹435 Cr | 12.09 | |
Jun2023 | ₹388 Cr | -28.85 | |
Mar2023 | ₹545 Cr | - |
HIKAL Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -3.74 % |
Y-o-Y | 11.44 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹72 Cr | -3.74 | |
Sep2024 | ₹75 Cr | 29.14 | |
Jun2024 | ₹58 Cr | -38.60 | |
Mar2024 | ₹94 Cr | 46.00 | |
Dec2023 | ₹65 Cr | 12.33 | |
Sep2023 | ₹58 Cr | 14.51 | |
Jun2023 | ₹50 Cr | -42.85 | |
Mar2023 | ₹88 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -2.66 % |
Y-o-Y | 11.34 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 16.1% | -2.66 | |
Sep2024 | 16.54% | 15.99 | |
Jun2024 | 14.26% | -22.37 | |
Mar2024 | 18.37% | 27.04 | |
Dec2023 | 14.46% | 9.21 | |
Sep2023 | 13.24% | 2.16 | |
Jun2023 | 12.96% | -19.70 | |
Mar2023 | 16.14% | - |
HIKAL Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -6.01 % |
Y-o-Y | 6.83 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹17 Cr | -6.01 | |
Sep2024 | ₹18 Cr | 258.82 | |
Jun2024 | ₹5 Cr | -84.99 | |
Mar2024 | ₹34 Cr | 110.99 | |
Dec2023 | ₹16 Cr | 27.78 | |
Sep2023 | ₹13 Cr | 82.61 | |
Jun2023 | ₹7 Cr | -80.83 | |
Mar2023 | ₹36 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -4.95 % |
Y-o-Y | 6.67 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 3.84 % | -4.95 | |
Sep2024 | 4.04 % | 223.20 | |
Jun2024 | 1.25 % | -81.09 | |
Mar2024 | 6.61 % | 83.61 | |
Dec2023 | 3.6 % | 24.14 | |
Sep2023 | 2.9 % | 62.92 | |
Jun2023 | 1.78 % | -73.03 | |
Mar2023 | 6.6 % | - |
HIKAL Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -6.08 % |
Y-o-Y | 6.92 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹1.39 | -6.08 | |
Sep2024 | ₹1.48 | 260.98 | |
Jun2024 | ₹0.41 | -85.14 | |
Mar2024 | ₹2.76 | 112.31 | |
Dec2023 | ₹1.3 | 27.45 | |
Sep2023 | ₹1.02 | 82.14 | |
Jun2023 | ₹0.56 | -80.82 | |
Mar2023 | ₹2.92 | - |
You may also like the below Video Courses